Medimetriks Pharmaceuticals, Inc. Submits NDA to FDA for Ozenoxacin Cream for Impetigo

FAIRFIELD, N.J., June 27, 2016 /PRNewswire/ -- Medimetriks Pharmaceuticals, Inc. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of ozenoxacin cream, 1%, a novel,...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news